Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
JAMA Network Open
|
June 25, 2026
Automated Speech-Based Modeling of Item-Level Symptom Severity in Schizophrenia
Silvia Ciampelli, Janna N de Boer, Sanne Koops, et al.
Psychological Medicine
|
September 8, 2025
Dopamine D<sub>2/3</sub>R availability after discontinuation of antipsychotic treatment: a [<sup>11</sup>C]raclopride PET study in remitted first-episode psychosis patients
Franciska de Beer, Erik de Vries, Ben Wijnen, et al.
JAMA Psychiatry
|
October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial
Iris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Schizophrenia (Heidelberg, Germany)
|
July 19, 2022
Occurrence and phenomenology of hallucinations in the general population: A large online survey
Mascha M J Linszen, Janna N de Boer, Maya J L Schutte, et al.
Scientific Reports
|
January 14, 2021
Functional connectome differences in individuals with hallucinations across the psychosis continuum
Maya J L Schutte, Marc M Bohlken, Guusje Collin, et al.
Scientific Reports
|
April 15, 2021
Author Correction: Functional connectome differences in individuals with hallucinations across the psychosis continuum
Maya J L Schutte, Marc M Bohlken, Guusje Collin, et al.
Schizophrenia Bulletin
|
July 12, 2022
Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Ondine Adam, Martin Blay, Andre R Brunoni, et al.
Schizophrenia Bulletin
|
February 20, 2021
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
Iris E Sommer, Shiral S Gangadin, Lot D de Witte, et al.
Journal of Psychiatric Research
|
November 22, 2020
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients
Niels Jongs, Brenda Penninx, Celso Arango, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
August 11, 2021
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer's disease
Ilja M J Saris, Moji Aghajani, Lianne M Reus, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
JAMA Network Open
|
June 25, 2026
Automated Speech-Based Modeling of Item-Level Symptom Severity in Schizophrenia
Silvia Ciampelli, Janna N de Boer, Sanne Koops, et al.
Psychological Medicine
|
September 8, 2025
Dopamine D<sub>2/3</sub>R availability after discontinuation of antipsychotic treatment: a [<sup>11</sup>C]raclopride PET study in remitted first-episode psychosis patients
Franciska de Beer, Erik de Vries, Ben Wijnen, et al.
JAMA Psychiatry
|
October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial
Iris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Schizophrenia (Heidelberg, Germany)
|
July 19, 2022
Occurrence and phenomenology of hallucinations in the general population: A large online survey
Mascha M J Linszen, Janna N de Boer, Maya J L Schutte, et al.
Scientific Reports
|
January 14, 2021
Functional connectome differences in individuals with hallucinations across the psychosis continuum
Maya J L Schutte, Marc M Bohlken, Guusje Collin, et al.
Scientific Reports
|
April 15, 2021
Author Correction: Functional connectome differences in individuals with hallucinations across the psychosis continuum
Maya J L Schutte, Marc M Bohlken, Guusje Collin, et al.
Schizophrenia Bulletin
|
July 12, 2022
Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Ondine Adam, Martin Blay, Andre R Brunoni, et al.
Schizophrenia Bulletin
|
February 20, 2021
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
Iris E Sommer, Shiral S Gangadin, Lot D de Witte, et al.
Journal of Psychiatric Research
|
November 22, 2020
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients
Niels Jongs, Brenda Penninx, Celso Arango, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
August 11, 2021
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer's disease
Ilja M J Saris, Moji Aghajani, Lianne M Reus, et al.
Page
of 6